Cancer Drug's hidden heart risk revealed in small study
NCT ID NCT04813913
First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study looked at 13 adults with advanced colorectal cancer who were starting treatment with bevacizumab (Avastin) plus chemotherapy. The goal was to measure changes in artery stiffness and blood pressure over 4 months to better understand the drug's side effects on the heart and blood vessels. The research did not test a new treatment but aimed to gather knowledge about how this existing therapy affects the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de ROUEN
Rouen, France
Conditions
Explore the condition pages connected to this study.